Opportunity timeline
In plain English
The CDC wants research, program, and operational support for the National ALS Biorepository under the ALS Registry Act. This is a small-business set-aside with an expected performance period from September 28, 2026, through September 27, 2031. Offers are due September 17, 2026, at 10 a.m. Eastern Time, and questions are due September 11, 2026, at 5 p.m. Eastern Time.
About this opportunity
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 75D301-26-Q-95343 is issued as a Request for Quotation for the project titled: "Facilitating Research, Programmatic, and Operational Support of the National Amyotrophic Lateral Sclerosis’ (ALS) Biorepository in support of the ALS Registry Act." This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses…
Time remaining
Closes Sep 17, 2026
Related Opportunities

Blood Products & Immunohematology Reference Laboratory for the LIH

Cadavers

Costal Cartilage Allograft (BAMC, San Antonio, Texas)

VISN 7 Blood and Blood-Related Products

Specialized Blood Products-AABB
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-478F76

